Premier Alternatives

Sonavex

Baltimore, MD · Founded 2013 · Privately Held (backing)

Developer of a bioresorbable and echogenic equipment technology designed to mark at-risk blood vessels. Sonavex is based in Baltimore, MD and was founded in 2013. Its last known valuation is $45 million. It has raised $24.1 million across 4 recorded rounds; the latest was a $15 million early-stage round in Aug 2021.

Last price · $/share
—
Implied valuation
$45.0M
Total raised
$24.1M
Last round
Early Stage VC
Aug 2021

Sonavex key facts

  • Developer of a bioresorbable and echogenic equipment technology designed to mark at-risk blood vessels.
  • Sonavex’s last known valuation is $45.0M.
  • It has raised $24.1M across 4 recorded rounds; the latest was Early Stage VC ($15.0M) in Aug 2021.
  • Notable investors include US National Science Foundation, MedTech Innovator, Gaingels, National Institutes of Health, Keiretsu Forum — 41 tracked in total.
  • Sonavex has filed 7 Form Ds with the SEC since 2015, most recently Nov 2024 ($15.0M sold to 45 investors).
  • Status: Privately Held (backing).
Free account
More of Sonavex with a free account
  • ·The complete investor list: 41 names
  • ·Watch Sonavex: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Sonavex funding rounds

4 rounds
Aug 2021Early Stage VC$15.0MSEC filing▮
Oct 2019Seed Round$1.8MSEC filing▮
Aug 2016Seed Round$2.2MSEC filing▮
Oct 2015Seed Round$320KSEC filing▮
Full funding history →

Sonavex valuation

Sonavex's last known valuation is $45 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How much has Sonavex raised?

Sonavex has raised $24.1 million across 4 recorded rounds since 2015. The largest was a $320,192 seed round in Oct 2015; the most recent was a $15 million early-stage round in Aug 2021.

Sonavex has filed 7 Form Ds with the SEC since 2015, most recently in Nov 2024 ($15 million sold to 45 investors).

Sonavex investors

41 investors are on record for Sonavex, including US National Science Foundation, MedTech Innovator, Gaingels and National Institutes of Health. By type, the record holds 7 venture capital firms and 2 family offices. The early-stage round in Aug 2021 drew 45 investors.

About Sonavex

Developer of a bioresorbable and echogenic equipment technology designed to mark at-risk blood vessels. The company's technology collects arteriovenous fistula volumetric flow rate, diameter, and depth information at the dialysis clinic to support maturation assessment, such that the site can be easily assessed for future complications, enabling healthcare providers to determine blood flow and morphology of vessels and get actionable data to deliver patient care.

Sector
Healthcare
HQ
Baltimore, MD, United States
Founded
2013
Employees
24
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation on record
$45.0M

Sonavex’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.